Vincent KaufmannVincent Kaufmann is associate professor of urban sociology and mobility at Ecole Polytechnique Fédérale de Lausanne (EPFL). Since 2011, he is also scientific director of the Mobile Lives Forum in Paris. After a master degree in sociology (Universtiy of Geneva) he did his Ph.D. at EPFL on rationalities underlying transport modal practices. Vincent Kaufmann has been invited lecturer at Lancaster University (2000-2001), Ecole des Ponts et Chaussées, Paris (2001-2002), Laval University, Québec (2008) Nimegen University (2010), Université de Toulouse Le Mirail (2011), Université Catholique de Louvain (2004-2018) and Tongji University in Shanghai (2018). There fields of research are: motility, mobility and urban life styles, links between social and spatial mobility, public policies of land planning and transportation. He recently published “Mobilité et libre circulation en Europe” (with Ander Audikana) Economica (2017).
Pierre GönczyPierre Gönczy obtained his PhD from The Rockefeller University (New York, USA) in 1995 and joined the laboratory of Tony Hyman at the EMBL (Heidelberg, Germany) as a postdoctoral fellow in 1996. He started his own laboratory at ISREC in 2000. In 2005, he became Associate Professor at the EPFL School of Life Sciences, and was promoted Full Professor in 2009.
Johan AuwerxJohan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.
